ATE424732T1 - Zubereitungen enthaltend mehrfach ungesättigte phospholipide, monoterpene und tryptophan und/oder phytol-derivate - Google Patents

Zubereitungen enthaltend mehrfach ungesättigte phospholipide, monoterpene und tryptophan und/oder phytol-derivate

Info

Publication number: ATE424732T1
Authority: AT; Austria
Prior art keywords: tryptophan; phospholipides; monoterpenes; linolenic acid; acid
Prior art date: 2003-01-13

Application number

AT04700674T

Other languages

English (en)

Inventor

Elvira Pistolesi

Original Assignee

Hunza Di Pistolesi Elvira E C

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-01-13

Filing date

2004-01-08

Publication date

2009-03-15

2004-01-08 Application filed by Hunza Di Pistolesi Elvira E C filed Critical Hunza Di Pistolesi Elvira E C

2009-03-15 Application granted granted Critical

2009-03-15 Publication of ATE424732T1 publication Critical patent/ATE424732T1/de

Links

QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 title abstract 2
BOTWFXYSPFMFNR-PYDDKJGSSA-N phytol Chemical class CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CO BOTWFXYSPFMFNR-PYDDKJGSSA-N 0.000 title abstract 2
238000002360 preparation method Methods 0.000 title abstract 2
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 title 1
229930003658 monoterpene Natural products 0.000 title 1
150000002773 monoterpene derivatives Chemical class 0.000 title 1
235000002577 monoterpenes Nutrition 0.000 title 1
MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 2
DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 abstract 2
CQJSGBBQLZEEST-QNEBEIHSSA-N (6z,9z,12z)-2,3-dioxooctadeca-6,9,12-trienoic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCC(=O)C(=O)C(O)=O CQJSGBBQLZEEST-QNEBEIHSSA-N 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
150000007513 acids Chemical class 0.000 abstract 1
230000032683 aging Effects 0.000 abstract 1
JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 abstract 1
235000020661 alpha-linolenic acid Nutrition 0.000 abstract 1
229940054051 antipsychotic indole derivative Drugs 0.000 abstract 1
235000005911 diet Nutrition 0.000 abstract 1
230000000378 dietary effect Effects 0.000 abstract 1
235000020669 docosahexaenoic acid Nutrition 0.000 abstract 1
229940090949 docosahexaenoic acid Drugs 0.000 abstract 1
235000020673 eicosapentaenoic acid Nutrition 0.000 abstract 1
229960005135 eicosapentaenoic acid Drugs 0.000 abstract 1
JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 abstract 1
235000013376 functional food Nutrition 0.000 abstract 1
VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 abstract 1
VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 abstract 1
235000020664 gamma-linolenic acid Nutrition 0.000 abstract 1
229960002733 gamolenic acid Drugs 0.000 abstract 1
238000001727 in vivo Methods 0.000 abstract 1
150000002475 indoles Chemical class 0.000 abstract 1
229960004488 linolenic acid Drugs 0.000 abstract 1
230000002503 metabolic effect Effects 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000003921 oil Substances 0.000 abstract 1
150000003904 phospholipids Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Health & Medical Sciences (AREA)
Nutrition Science (AREA)
Mycology (AREA)
Food Science & Technology (AREA)
Polymers & Plastics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oil, Petroleum & Natural Gas (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Cosmetics (AREA)

AT04700674T 2003-01-13 2004-01-08 Zubereitungen enthaltend mehrfach ungesättigte phospholipide, monoterpene und tryptophan und/oder phytol-derivate ATE424732T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT000036A ITMI20030036A1 (it)	2003-01-13	2003-01-13	Preparazioni farmacologiche o dietetiche costituite da

Publications (1)

Publication Number	Publication Date
ATE424732T1 true ATE424732T1 (de)	2009-03-15

Family

ID=32652445

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT04700674T ATE424732T1 (de)	2003-01-13	2004-01-08	Zubereitungen enthaltend mehrfach ungesättigte phospholipide, monoterpene und tryptophan und/oder phytol-derivate

Country Status (5)

Country	Link
EP (1)	EP1583433B1 (de)
AT (1)	ATE424732T1 (de)
DE (1)	DE602004019884D1 (de)
IT (1)	ITMI20030036A1 (de)
WO (1)	WO2004062389A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20060023558A (ko) *	2003-06-17	2006-03-14	디에스엠 아이피 어셋츠 비.브이.	피탄산 또는 그의 유도체를 함유하는 국소제
TWI365716B (en) *	2003-12-02	2012-06-11	Suntory Holdings Ltd	Oil or fat and oil compositions containing phospholipids and a long-chain polyunsaturated fatty acid supply compound, and food using same
DE102005019951A1 (de) *	2005-04-27	2006-11-09	Beiersdorf Ag	Kosmetische Zubereitungen enthaltend Pristansäure
EP2001561A2 (de) *	2006-03-31	2008-12-17	DSMIP Assets B.V.	Neue verwendung von verbindungen und kombinationen aus verbindungen zur verbesserung des physischen erscheinungsbildes
US20070298133A1 (en) *	2006-06-23	2007-12-27	The Procter & Gamble Company	Compositions and kits comprising a melatonin component and a flavanol component
US20070299127A1 (en) *	2006-06-23	2007-12-27	The Procter & Gamble Company	Compositions and kits comprising a melatonin component and an omega-3-fatty acid component
KR20100061548A (ko) *	2007-10-18	2010-06-07	디에스엠 아이피 어셋츠 비.브이.	티몰 및/또는 ｐ-시멘 또는 식물 추출물을 함유하는 인지 개선용 신규 기능식품성 조성물
WO2011018096A1 (en) *	2009-08-10	2011-02-17	K.D. Pharma Bexbach Gmbh	Phytanic acid fractionation process, fatty acid products and use thereof
RU2606841C2 (ru) *	2010-09-03	2017-01-10	Н.В. Нютрисиа	Способ и препарат для лечения или профилактики тревожности или нейрогенеза
ITMI20112042A1 (it) *	2011-11-10	2013-05-11	Eratech S R L	Polvere da ricostituire prima dell'uso comprendente melatonina e preparazione iniettabile ottenibile da tale polvere.
IN2014DN10037A (de) *	2012-05-21	2015-08-14	Ocean Nutrition Canada Ltd
CN104507324A (zh)	2012-07-31	2015-04-08	帝斯曼营养产品股份公司	使用绿茶提取物抗氧化剂精制油
AU2013381790A1 (en) *	2013-03-13	2015-10-22	Alevere Medical Corporation	Use of indole compounds for fat reduction and skin and soft tissue tightening
EP3060215A4 (de)	2013-10-21	2017-06-14	Alevere Medical Corporation	Kondensierte heterocyclische organische verbindungen, pharmazeutische zusammensetzungen und medizinische verwendungen davon
IT201600105201A1 (it) *	2016-10-19	2018-04-19	Nutrilinea Srl	Uso della fosfatidilserina per la prevenzione e il trattamento dei disturbi della prostata e relative composizioni farmaceutiche e nutraceutiche

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9101642D0 (sv) *	1991-05-30	1991-05-30	Kabi Pharmacia Ab	Phospholipids
AT407821B (de) *	1998-03-24	2001-06-25	Franz Dr Stueckler	Mittel auf der basis von naturstoffen
IT1320180B1 (it) *	2000-12-29	2003-11-26	Hunza Di Marazzita Maria Carme	Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e

2003
- 2003-01-13 IT IT000036A patent/ITMI20030036A1/it unknown
2004
- 2004-01-08 AT AT04700674T patent/ATE424732T1/de not_active IP Right Cessation
- 2004-01-08 DE DE602004019884T patent/DE602004019884D1/de not_active Expired - Fee Related
- 2004-01-08 WO PCT/EP2004/000066 patent/WO2004062389A1/en not_active Ceased
- 2004-01-08 EP EP04700674A patent/EP1583433B1/de not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP1583433B1 (de)	2009-03-11
ITMI20030036A1 (it)	2004-07-14
DE602004019884D1 (de)	2009-04-23
EP1583433A1 (de)	2005-10-12
WO2004062389A1 (en)	2004-07-29

Similar Documents

Publication	Publication Date	Title
ATE424732T1 (de)	2009-03-15	Zubereitungen enthaltend mehrfach ungesättigte phospholipide, monoterpene und tryptophan und/oder phytol-derivate
CN1245984C (zh)	2006-03-22	用于预防和/或治疗血管疾病的制剂
WO2008147562A3 (en)	2009-07-16	Dietary formulations and methods for treatment of inflammation and other disorders
PT2170090E (pt)	2011-07-01	Óleos enriquecidos com hidroxitirosol e suas utilizações
Lee et al.	2013	Effect of quercetin-rich onion peel extracts on arterial thrombosis in rats
BRPI0509017A (pt)	2007-08-07	composições hmb e utilizações das mesmas
WO2008147482A3 (en)	2009-12-30	Methods and compositions for improving immune responses
ATE514345T1 (de)	2011-07-15	Zusammensetzung zur senkung des blutcholesterolspiegels
IN2014DN06125A (de)	2015-08-14
EA200970374A1 (ru)	2009-10-30	Лечение антиаритмическими средствами и омега-3 жирными кислотами и их комбинированным продуктом
MX2010003703A (es)	2010-07-30	Composicion que comprende acidos grasos poliinsaturados y carbon activado.
EP4342532A3 (de)	2024-07-17	Antiplättchenarzneimittel und verwendungen davon
US20100160427A1 (en)	2010-06-24	Method of treating vascular injuries induced by an excess of plasma lipids using combinations of vasoprotective agents
JP2014088333A (ja)	2014-05-15	口腔咽頭用組成物
MX2010003843A (es)	2010-07-30	Composicion orodispersable que comprende acidos grasos poliinsaturados sin mal olor ni sabor.
WO2005112915A3 (en)	2006-03-16	Decrease in oxidative stress status through the administration of natural products and pharmaceutical drugs
AR083460A1 (es)	2013-02-27	Hidrolizados de proteinas animales de origen marino con propiedades neuroprotectoras
WO2006111633A3 (fr)	2007-04-05	Utilisation de la lecithine comme medicament dans le traitement du psoriasis
PH12016501111A1 (en)	2016-08-15	Composition comprising ferric saccharate and high concentrations of microencapsulated lc-pufa with a reduced off taste
US20060009486A1 (en)	2006-01-12	Composition and method for treatment and prevention of coronary artery disease
Tawfik	2016	Anti-aggregatory effect of boswellic acid in high-fat fed rats: involvement of redox and inflammatory cascades
MX2024012638A (es)	2024-12-06	Composicion que comprende n-acetilcisteina, vitamina d y preferentemente glutation, usos de la misma, y composiciones farmaceuticas y nutraceuticas de los mismos
CA2827555A1 (en)	2012-08-23	Cholesterol absorption inhibitor (azetidinone) and omega 3 fatty acids (epa, dha, dpa) for the reduction of cholesterol and for the reduction of cardiovascular events
ES2413497B1 (es)	2014-05-14	Composición con alto contenido en Omega 3, Omega 6 y Omega 9
EA201070459A1 (ru)	2010-10-29	Аминооксимные производные 2- и/или 4-замещенных андростанов и андростенов в качестве лекарственных средств для лечения сердечно-сосудистых нарушений

Legal Events

Date	Code	Title	Description
2009-09-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties